EXAS logo

EXAS
Exact Sciences Corp.

11,228
Mkt Cap
$19.7B
Volume
2.12M
52W High
$103.54
52W Low
$38.81
PE Ratio
-19.42
EXAS Fundamentals
Price
$103.24
Prev Close
$103.23
Open
$103.23
50D MA
$102.06
Beta
0.85
Avg. Volume
2.45M
EPS (Annual)
-$1.10
P/B
7.82
Rev/Employee
$450,970.83
$20,733.24
Loading...
Loading...
News
all
press releases
CSLLY vs. EXAS: Which Stock Is the Better Value Option?
CSLLY vs. EXAS: Which Stock Is the Better Value Option?
Zacks·8h ago
News Placeholder
More News
News Placeholder
Illinois Municipal Retirement Fund Boosts Stake in Exact Sciences Corporation $EXAS
Illinois Municipal Retirement Fund lifted its holdings in Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 20.1% during the third quarter, according to its most recent 13F filing with the...
MarketBeat·3d ago
News Placeholder
Exact Sciences Q4 Loss Narrows As Revenues Gain
(RTTNews) - Exact Sciences Corporation (EXAS) on Friday, reported higher revenue for both the fourth quarter and full year ended December 31, 2025, while significantly narrowing its losses...
Nasdaq News: Markets·3d ago
News Placeholder
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
Exact Sciences (EXAS) delivered earnings and revenue surprises of -8,300.00% and +2.07%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
Exact Sciences Earnings Review: Q4 Summary
read more...
Benzinga·3d ago
News Placeholder
Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $878 million for the fourth quarter of 2025 and...
Business Wire·3d ago
News Placeholder
Exact Sciences Corporation (NASDAQ:EXAS) Given Consensus Rating of "Hold" by Brokerages
Exact Sciences Corporation (NASDAQ:EXAS - Get Free Report) has earned a consensus recommendation of "Hold" from the twenty-four ratings firms that are presently covering the company, Marketbeat...
MarketBeat·5d ago
News Placeholder
Skylands Capital LLC Increases Stake in Exact Sciences Corporation $EXAS
Skylands Capital LLC increased its stake in Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 54.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund...
MarketBeat·5d ago
News Placeholder
Allianz Asset Management GmbH Makes New Investment in Exact Sciences Corporation $EXAS
Allianz Asset Management GmbH acquired a new stake in Exact Sciences Corporation (NASDAQ:EXAS - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC...
MarketBeat·6d ago
News Placeholder
IQ EQ FUND MANAGEMENT IRELAND Ltd Purchases Shares of 75,662 Exact Sciences Corporation $EXAS
IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new stake in Exact Sciences Corporation (NASDAQ:EXAS - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the...
MarketBeat·10d ago
<
1
2
...
>

Latest EXAS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.